Translational Proteomics

Efforts in JRA3 are focused on making translational proteome profiling a more main-stream technology in the clinical setting. Enabling proteomics technologies will be developed to support analyzing larger cohorts of patient samples, i.e. plasma, organoids, tissue biopsies. This JRA involves partners UU, VIB, UCPH, CNIO and IEO.